ESP - GS1 Pharma Serialisation Industry Readiness Survey Report 2017

A 2017 Pharma Serialisation Readiness Report focusing on industry readiness for the EU FMD deadlines, conducted by GS1 Ireland and ESP

Pharma Serialisation and the EU Falsified Medicines Directive

In a recently published shared vision for product identification, the European Federation of Pharmaceutical Industries and Associations (EFPIA) supports the use of GS1 standards for the identification of products.

GS1 FMD Training and Advice

Advice and training from GS1 experts on implementing GS1 identification, barcoding and labelling standards such as GTINs, AIs and Data Matric Symbols for global serialisation requirements such as the EU falsified Medicines Directive (FMD).

Falsified Medicines Directive - Compliance date confirmed

Delegated Acts on safety features in the EU Falsified Medicines Directive (FMD) have been published and a compliance date set.

Draft European Falsified Medicine Regulation Issued

Draft directive issued for a unique identifier and an anti-tampering safety feature to prevent falsified medicine in the supply chain in Europe